Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
Journal of Zhejiang University. Medical sciences ; (6): 591-600, 2021.
Article in English | WPRIM | ID: wpr-922265

ABSTRACT

To investigate effects of α-asarone and β-asarone on induced PC12 cell injury and related mechanisms. Aβ toxic injury cell model was induced by Aβ in PC12 cells. PC12 cells were divided into blank control group, model control group, α-asarone group (0.5, 1.0, β-asarone group (6.3, 12.5, vasoactive intestinal peptide (VIP) group, and VIP antagonist control group. Cell survival rate was detected by CCK-8 kit; cell apoptosis rate was detected by flow cytometry. The levels of inflammatory cytokines interleukin (IL)-1, , tumor necrosis factor (TNF)-α, oxidation-related inducible nitric oxide synthase (iNOS), nitric oxide (NO), apoptosis factors caspase-3 and p53 were detected by ELISA method. The expressions of C-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38MAPK) were detected by Western blotting. Compared with model control group, cell survival rates of group, β-asarone group and VIP group increased; the cell apoptosis rate decreased; levels of apoptosis-related factors caspase-3, p53, inflammatory factors IL-1, TNF-α decreased; IL-10 level increased; levels of oxidization-related factors iNOS and NO decreased; the expression of JNK and p38MAPK protein decreased (all 0.05). α-asarone and β-asarone have protective effects on PC12 cell injury induced by Aβ. β-asarone may inhibit inflammatory factors and oxidation-related factors through promoting VIP secretion, regulating JNK/MAPK pathway, and reducing PC12 cell apoptosis; however, the effect of α-asarone may be not related to VIP secretion.


Subject(s)
Animals , Rats , Allylbenzene Derivatives , Anisoles/pharmacology , Apoptosis , PC12 Cells
2.
Braz. j. med. biol. res ; 51(8): e7129, 2018. tab, graf
Article in English | LILACS | ID: biblio-951738

ABSTRACT

Primordial follicles, the main source of oocytes in the ovary, are essential for the maintenance of fertility throughout the reproductive lifespan. To the best of our knowledge, there are no reports describing the effect of anethole on this important ovarian follicle population. The aim of the study was to investigate the effect of different anethole concentrations on the in vitro culture of caprine preantral follicles enclosed in ovarian tissue. Randomized ovarian fragments were fixed immediately (non-cultured treatment) or distributed into five treatments: α-MEM+ (cultured control), α-MEM+ supplemented with ascorbic acid at 50 μg/mL (AA), and anethole at 30 (AN30), 300 (AN300), or 2000 µg/mL (AN2000), for 1 or 7 days. After 7 days of culture, a significantly higher percentage of morphologically normal follicles was observed when anethole at 2000 μg/mL was used. For both culture times, a greater percentage of growing follicles was observed with the AN30 treatment compared to AA and AN2000 treatments. Anethole at 30 and 2000 µg/mL concentrations at days 1 and 7 of culture resulted in significantly larger follicular diameter than in the cultured control treatment. Anethole at 30 µg/mL concentration at day 7 showed significantly greater oocyte diameter than the other treatments, except when compared to the AN2000 treatment. At day 7 of culture, levels of reactive oxygen species (ROS) were significantly lower in the AN30 treatment than the other treatments. In conclusion, supplementation of culture medium with anethole improves survival and early follicle development at different concentrations in the caprine species.


Subject(s)
Animals , Female , Oxidative Stress/drug effects , In Vitro Oocyte Maturation Techniques/veterinary , Ovarian Follicle/growth & development , Anisoles/pharmacology , Goats , Immunohistochemistry , Random Allocation , Culture Media , Dose-Response Relationship, Drug , In Vitro Oocyte Maturation Techniques/methods , Ovarian Follicle/drug effects , Anisoles/administration & dosage
3.
Indian J Physiol Pharmacol ; 1995 Jan; 39(1): 63-7
Article in English | IMSEAR | ID: sea-106585

ABSTRACT

Trans-anethole was studied for antifertility activity in rats at dose levels of 50 mg, 70 mg and 80 mg/kg po. Dose-dependent activity was observed, a 100% anti-implantation activity being achieved at 80 mg/kg, po. The compound showed a significant estrogenic activity and did not possess anti-estrogenic, progestational, anti-progestational, androgenic or anti-androgenic activities. In an earlier study, the compound was found to be safe, its LD50 being more than 3000 mg/kg, po in mice.


Subject(s)
Abortion, Induced , Animals , Anisoles/pharmacology , Contraceptives, Oral/pharmacology , Dose-Response Relationship, Drug , Estradiol/pharmacology , Estrogens/administration & dosage , Female , Fertility/drug effects , Lethal Dose 50 , Male , Organ Size/drug effects , Ovariectomy , Pregnancy , Prostate/drug effects , Rats , Seminal Vesicles/drug effects , Testosterone/pharmacology
4.
Yonsei Medical Journal ; : 106-113, 1986.
Article in English | WPRIM | ID: wpr-79331

ABSTRACT

Effects of feeding 2(3)-tert-butyl 4-hydroxyanisole (BHA) and 3, 5-di-tert-butyl 4-hydroxytoluene (BHT) on the rates of mixed function oxidation and conjugation enzyme reactions have been determined using isolated hepatic microsomal fractions and isolated perfused livers of mice. The treatments with either of the antioxidants have increased the rates of O-demethylation for p-nitroanisole and of O-deethylation for 7-ethoxycoumarin up to 2-fold, both in microsomes and in perfused liver. Analysis of the perfusate showed that the increased amounts of p-nitrophenol and 7-hydroxycoumarin produced by the elevated mixed-function oxidase activities were reflected by the increase in the amounts of glucuronide conjugates and not in the increase for the amounts of the sulfate ester conjugates. Comparison of results also indicated that in the perfused liver, the maximal rate of metabolite conjugation is limited by the maximal rates of the initial mixed function oxidase activities.


Subject(s)
Female , Mice , Alkylation , Animals , Anisoles/metabolism , Anisoles/pharmacology , Butylated Hydroxyanisole/administration & dosage , Butylated Hydroxyanisole/pharmacology , Butylated Hydroxytoluene/administration & dosage , Butylated Hydroxytoluene/analogs & derivatives , Butylated Hydroxytoluene/pharmacology , Comparative Study , Coumarins/metabolism , Glucuronosyltransferase/metabolism , Liver/metabolism , Microsomes, Liver/enzymology , Microsomes, Liver/metabolism , Mixed Function Oxygenases/metabolism , Oxidation-Reduction , Perfusion
6.
Yonsei Medical Journal ; : 95-100, 1981.
Article in English | WPRIM | ID: wpr-225822

ABSTRACT

An experiment was conducted in order to investigate the effect of p-dimethylaminoazobenzene (DAB) and 2(3)-tert-butyl-4-hydroxyanisole (BHA) on the lipid peroxidation and peroxide-destroying enzyme system in the rat liver. Dietary supplementation of DAB (0.06%) for three weeks caused the elevation of glutathione-S-transferase activity by 60% and glutathione reductase by 50%, but it decreased glutathione peroxidase and catalase activities significantly. Dietary supplementation of BHA (0.75%) also increased glutatione-S-transferase activity in the liver by 2 folds, and it counteracts DAB effect on the glutathione peroxidase and catalase activities. There was a marked increase in malon-dialdehyde content in the postnuclear fraction of liver by the treatment of DAB, but the addition of BHA lowered the malondialdehyde content to almost the control level. The protective effect of BHA on the lipid peroxidation induced by DAB administration at the enzyme level seems to be due to the induction of glutathione-S-transferase and the protection of glutathione peroxidase and catalase activities from being lowered by DAB administration.


Subject(s)
Male , Rats , Animals , Anisoles/pharmacology , Butylated Hydroxyanisole/pharmacology , Glutathione Peroxidase/analysis , Glutathione Reductase/analysis , Glutathione Transferase/analysis , Lipid Peroxides/metabolism , Liver/drug effects , Liver/metabolism , Peroxidases/analysis , p-Dimethylaminoazobenzene/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL